News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,560 Results
Type
Article (3594)
Company Profile (13)
Press Release (52953)
Section
Business (21377)
Career Advice (66)
Deals (3746)
Drug Delivery (10)
Drug Development (4087)
Employer Resources (12)
FDA (825)
Job Trends (1054)
News (28989)
Policy (1305)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (238)
Allergies (3)
Alliances (5142)
ALS (5)
Alzheimer's disease (120)
Antibody-drug conjugate (ADC) (6)
Approvals (824)
Artificial intelligence (40)
Autoimmune disease (3)
Bankruptcy (32)
Best Places to Work (748)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (13)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (12)
Cancer (117)
Cardiovascular disease (9)
Career advice (59)
Career pathing (3)
CAR-T (13)
Cell therapy (32)
Clinical research (3116)
Collaboration (75)
Compensation (3)
Complete response letters (1)
COVID-19 (157)
CRISPR (4)
C-suite (37)
Cystic fibrosis (14)
Data (118)
Denatured (2)
Depression (4)
Diabetes (13)
Diagnostics (573)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (18)
Drug pricing (11)
Duchenne muscular dystrophy (3)
Earnings (4285)
Editorial (4)
Employer resources (10)
Events (5198)
Executive appointments (113)
FDA (887)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (345)
Gene editing (10)
Generative AI (3)
Gene therapy (25)
GLP-1 (64)
Government (125)
Guidances (4)
Healthcare (1249)
Huntington's disease (1)
IgA nephropathy (3)
Immunology and inflammation (15)
Indications (1)
Infectious disease (165)
Inflammatory bowel disease (12)
Inflation Reduction Act (4)
Influenza (1)
Intellectual property (9)
Interviews (5)
IPO (1753)
IRA (8)
Job creations (316)
Job search strategy (57)
Labor market (5)
Layoffs (32)
Leadership (1)
Legal (273)
Liver cancer (3)
Lung cancer (16)
Lymphoma (6)
Machine learning (1)
Management (4)
Manufacturing (25)
MASH (6)
Medical device (1262)
Medtech (1264)
Mergers & acquisitions (2053)
Metabolic disorders (54)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (154)
NextGen: Class of 2025 (962)
Non-profit (290)
Northern California (215)
Now hiring (1)
Obesity (35)
Opinion (47)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (9)
Partnered (4)
Patents (8)
Patient recruitment (8)
Peanut (3)
People (8707)
Pharmaceutical (4)
Phase I (1056)
Phase II (1444)
Phase III (878)
Pipeline (63)
Podcasts (5)
Policy (14)
Postmarket research (95)
Preclinical (577)
Press Release (6)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (25)
Rare diseases (32)
Real estate (578)
Recruiting (5)
Regulatory (984)
Reports (3)
Research institute (167)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (4)
Series A (95)
Series B (67)
Service/supplier (1)
Sickle cell disease (1)
Southern California (156)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (2169)
Supply chain (4)
The Weekly (3)
United States (1394)
Vaccines (25)
Venture capitalists (35)
Webinars (4)
Weight loss (18)
Women's health (2)
Date
Today (12)
Last 7 days (51)
Last 30 days (222)
Last 365 days (2724)
2025 (721)
2024 (2913)
2023 (3075)
2022 (5513)
2021 (4847)
2020 (4664)
2019 (4302)
2018 (3457)
2017 (3033)
2016 (2521)
2015 (2908)
2014 (2099)
2013 (1739)
2012 (1852)
2011 (2067)
2010 (2165)
Location
Africa (63)
Alabama (5)
Alaska (2)
Arizona (10)
Arkansas (5)
Asia (3983)
Australia (479)
California (472)
Canada (420)
China (39)
Colorado (13)
Connecticut (25)
Delaware (5)
Europe (8097)
Florida (29)
Georgia (14)
Idaho (5)
Illinois (41)
India (5)
Indiana (18)
Iowa (1)
Japan (21)
Kansas (7)
Kentucky (1)
Louisiana (4)
Maine (6)
Maryland (41)
Massachusetts (281)
Michigan (8)
Minnesota (14)
Missouri (9)
Nevada (1)
New Hampshire (5)
New Jersey (71)
New Mexico (4)
New York (99)
North Carolina (57)
Northern California (215)
Ohio (22)
Oklahoma (3)
Oregon (2)
Pennsylvania (45)
Puerto Rico (3)
South America (97)
South Carolina (1)
Southern California (156)
Tennessee (6)
Texas (56)
Utah (14)
Virginia (8)
Washington D.C. (1)
Washington State (31)
Wisconsin (6)
56,560 Results for "khosla ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
C the Signs Announces Investment From Khosla Ventures to Advance AI-Powered Early Cancer Detection
January 31, 2025
·
3 min read
Pharm Country
Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs
Vivodyne today announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS Ventures, MBX Capital, and Bison Ventures.
November 22, 2023
·
6 min read
Biotech Bay
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
Encellin announced the closing of a $9.9M financing round led by Khosla Ventures, with participation from Y Combinator.
December 13, 2023
·
3 min read
Biotech Bay
Rejuvenation Technologies Raises $10.6M Seed Financing Led by Khosla Ventures to Develop mRNA Therapeutics to Reverse Aging
Rejuvenation Technologies , a biotechnology company developing mRNA-based therapeutics to address mechanisms of aging, today announced a $10.6M seed financing round led by Khosla Ventures. Shanda Ventures, Asymmetry Ventures, Merchant Adventures, Longevity Tech Fund, and Y Combinator also participated in the round.
September 6, 2023
·
4 min read
Biotech Bay
Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, announced the closing of a $40M Series A financing round.
April 22, 2024
·
3 min read
Biotech Bay
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Karius®, Inc., a world leader in genomic diagnostics for infectious disease, announced it has secured $100 million in Series C funding.
May 2, 2024
·
5 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Biotech Beach
Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating Diseases
Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system (CNS) diseases and disorders, today announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million.
November 28, 2022
·
4 min read
Genetown
Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
SiPhox Health, the leader in building the next generation of lab-grade home health testing with silicon photonics, raised $27 million in funding including a $10M Seed financing and a $17M Series A round.
July 19, 2023
·
4 min read
Deals
Valo Health, Khosla Ventures Terminate Merger Plans At Last Minute
Under the terms of their merger agreement, the deal can be terminated at any time. Know what happened between Valo Health & Khosla Ventures before the merger.
November 17, 2021
·
2 min read
·
Vanessa Doctor, RN
1 of 5,656
Next
